Column Group
GRTS icon

Column Group’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Column Group’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-869,493
Closed -$3.43M – 7
2020
Q4 		$3.43M Buy
+869,493
New +$2.63M 0.31% 7

Other funds holding GRTS

Versant Venture Management
Versant Venture Management San Francisco, California $109M AUM 43.78% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Palo Alto Investors
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Avidity Partners Management
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Column Group's GRTS Position: Q1 2021 in Review

Column Group sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2021, closing a stake of 869,493 shares — an estimated $3.43M sold.

Column Group first reported a position in GRTS in Q4 2020 and held it in 1 quarter. The position peaked at $3.43M in Q4 2020. 99 funds tracked by Wall St. Rank hold GRTS as of Q1 2021.

  • Column Group reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Column Group sold 869,493 Gritstone bio, Inc. Common Stock shares in Q1 2021, an estimated $3.43M.
  • Column Group first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Column Group's Gritstone bio, Inc. Common Stock position peaked at $3.43M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2021.

Based on Column Group's 13F filing for Q1 2021, filed 17 May 2021.